Exciting new research from the Drs. Bruce Perkins and Ahmad Haidar labs has been published in Nature Medicine. This project looks at how a combination therapy could have the potential to improve blood sugar control and the performance of an artificial pancreas.

The paper, “Empagliflozin add-on therapy to closed-loop insulin delivery in type 1 diabetes: a 2 × 2 factorial randomized crossover trial” can be accessed on the Nature Medicine Website.

JDRF and Diabetes Action Canada both provided funding support for this project.